NanoSynex
NanoSynex is developing a diagnostic test that can check bacterial resistance to antibiotics in a record time using microfluidics techniques, based on a revolutionary scientific development from the Technion. The test will help doctors determine the most appropriate antibiotic treatment for their patients and provide same day results, which will reduce the spread of resistant bacteria in the environment and significantly lower the burden on healthcare costs.
NanoSynex
Nanosynex provides rapid and personalized antibiotic susceptibility testing to combat antibiotic resistance and improve patient outcomes.
About
Needs Assessment
Active buying signals and potential business opportunities
Technology Requirements
Rapid AST technology
Microfluidic components and manufacturing equipment
Software for data analysis and reporting
LIMS (Laboratory Information Management System) integration tools
Data privacy and security solutions
Service Requirements
Regulatory consulting for medical device approvals
Training for lab personnel on using the AST platform
Technical support and maintenance for diagnostic equipment
Cloud hosting for data management and analysis
Consulting services for workflow optimization and automation
Infrastructure Requirements
Clinical labs
Diagnostic facilities
Data storage and processing infrastructure
Secure network infrastructure for data transmission
Compliance with relevant regulations
Talent Requirements
Microfluidics engineers
Software developers for data analysis and reporting
Regulatory affairs specialists
Sales and marketing professionals with experience in diagnostics
Lab technicians trained in antimicrobial susceptibility testing
AI Insights
Growth Trajectory
Based on participation in international events and focus on developing rapid AST technology, Nanosynex exhibits strong growth potential in the global diagnostics market.
Market Opportunity
Nanosynex has a strong market opportunity in providing rapid and personalized antibiotic susceptibility testing to combat antibiotic resistance and improve patient outcomes, offering a competitive advantage in the diagnostic market.
Access Our Live VC Funding Database
30,000+ funded startups
tracked in the last 3 months
B2B verified emails
of key decision makers
Growth metrics
Real-time company performance data
Live updates
of new VC funding rounds
Advanced filters
for sophisticated queries
API access
with multiple export formats